Pharmacopeia has earned a $1 million milestone payment as part of its collaboration with Biovitrum. The payment was triggered by Pharmacopeia’s delivery of an advanced lead compound to one of Biovitrum’s programs in diabetes. “Biovitrum has been an excellent partner for Pharmacopeia. They are committed to developing novel treatments for metabolic diseases, such as diabetes and obesity as well as for other indications like inflammation, blood and eye diseases and we see gre...